Search results for "TAVI"

showing 10 items of 342 documents

Dichrooscytus gustavi Josifov, 1981 (Heteroptera: Miridae) – pierwsze potwierdzone stanowisko w Polsce / Dichrooscytus gustavi Josifov, 1981 (Heterop…

2019

Dichrooscytus gustavi differs from D. rufipennis and D. intermedius primarily by a smaller size of the body and the entirely green scutellum. Its occurrence has been confirmed so far in more than ten European countries, where it was reported to live on Juniperus communis L. and also on different introduced species of Cupressaceae. In this note the first locality of this species in Poland is presented. Moreover, the authors explain a reason why D. valesianus [= at present D. gustavi] was removed from the list of species occurring in Poland (in the 2011’s Catalogue of Miridae of Poland), and suggest a possibility of the presence of D. gustavi in Poland as early as the first half of the …

HemipteraHeteropteratrue-bugsPoland.faunisticsdistributionDichrooscytus valesianusPolandconfirmed recordDichrooscytus gustavi
researchProduct

Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.

2003

In recent years, epitopes of various origin have been inserted into the core protein of hepatitis B virus (HBc), allowing the formation of chimeric HBc particles. Although the C-terminus of a C-terminally truncated HBc (HBcΔ) tolerates the insertion of extended foreign sequences, the insertion capacity is still a limiting factor for the construction of multivalent vaccines. Previously, we described a new system to generate HBcΔ mosaic particles based on a read-through mechanism in an <i>Escherichia coli</i> suppressor strain [J Gen Virol 1997;78:2049–2053]. Those mosaic particles allowed the insertion of a 114-amino acid (aa)-long segment of a Puumala hantavirus (PUUV) nucleocap…

Hepatitis B virusHepatitis B virus DNA polymerasevirusesRecombinant Fusion ProteinsMolecular Sequence Datamedicine.disease_causeEpitopeHepatitis B virus PRE betaMiceVirologyparasitic diseasesmedicineAnimalsNucleocapsidHantavirusHepatitis B virusMice Inbred BALB CBase SequenceChemistryHepatitis B virus coreVirionvirus diseasesNucleocapsid ProteinsVirologyMolecular biologyHepatitis B Core Antigensdigestive system diseasesStop codonNS2-3 proteaseInfectious DiseasesCodon TerminatorImmunizationIntervirology
researchProduct

Heavy quarkonium: progress, puzzles, and opportunities

2011

A golden age for heavy quarkonium physics dawned a decade ago, initiated by the confluence of exciting advances in quantum chromodynamics (QCD) and an explosion of related experimental activity. The early years of this period were chronicled in the Quarkonium Working Group (QWG) CERN Yellow Report (YR) in 2004, which presented a comprehensive review of the status of the field at that time and provided specific recommendations for further progress. However, the broad spectrum of subsequent breakthroughs, surprises, and continuing puzzles could only be partially anticipated. Since the release of the YR, the BESII program concluded only to give birth to BESIII; the $B$-factories and CLEO-c flo…

High Energy Physics - TheoryNuclear TheoryPhysics and Astronomy (miscellaneous)High Energy Physics::LatticeTevatronB-C MESON; QCD SUM-RULES; NUCLEUS COLLISIONSAtomic01 natural sciencesHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)Broad spectrumHigh Energy Physics - Phenomenology (hep-ph)Particle and Plasma Physicseffective field theoryBatavia TEVATRON CollNuclear Experiment (nucl-ex)Nuclear ExperimentNuclear ExperimentBrookhaven RHIC CollQuantum chromodynamicsPhysicsQuantum PhysicsLarge Hadron ColliderHigh Energy Physics - Lattice (hep-lat)lattice field theoryHERAQuarkoniumNuclear & Particles PhysicsCLEOB-C MESONHigh Energy Physics - PhenomenologyDESY HERA Stordecay [quarkonium]Jefferson LabParticle physicsFOS: Physical sciencesnonrelativistic [quantum chromodynamics]DeconfinementB-factoryNuclear Theory (nucl-th)High Energy Physics - Latticescattering [heavy ion]QCD SUM-RULES0103 physical sciencesNuclearddc:530010306 general physicsEngineering (miscellaneous)Particle Physics - Phenomenologyproduction [quarkonium]BES010308 nuclear & particles physicsHigh Energy Physics::Phenomenologyplasma [quark gluon]FísicaMoleculartetraquarkHigh Energy Physics - Theory (hep-th)[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]hadron spectroscopy [meson]hadron spectroscopy [quarkonium]High Energy Physics::Experimentheavy [quarkonium]NUCLEUS COLLISIONSThe European Physical Journal C
researchProduct

Octavien à la veille d’Actium chez Dion Cassius (L, 24-30 ): haranguer les troupes en diffamant l’adversaire

2014

1. Le compte-rendu des arguments Parmi les nombreuses interventions oratoires insérées dans l’œuvre de Dion Cassius qui montrent avant tout son intérêt à utiliser la rhétorique pour mettre au point des questions importantes sur le plan éthique-politique, en particulier à travers les discours tenus par certains personnages-clefs de l’histoire romaine, on peut distinguer la harangue prononcée devant ses troupes par Octavien à la veille de la bataille d’Actium en 31 av. J.-C. Quoiqu’il ne soit p...

Histoire[ SHS.HIST ] Humanities and Social Sciences/History[SHS.HIST] Humanities and Social Sciences/History[ SHS ] Humanities and Social Sciences[SHS] Humanities and Social Sciences[SHS.HIST]Humanities and Social Sciences/HistoryAntiquitéComputingMilieux_MISCELLANEOUSOttaviano; Azio; oratoria militare romana; Cassio Dione; Marco Antonio[SHS]Humanities and Social Sciences
researchProduct

Kalmbergin kartasto R VI : List 12

1855

HoutskariKustavimaastokartat1850-lukukartatIniöKorppoo
researchProduct

Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies

2004

International audience; DNA vaccination using a plasmid encoding the rotavirus inner capsid VP6 has been explored in the mouse model of rotavirus infection. BALB/c mice were immunized with a VP6 DNA vaccine by the intramuscular, nasal and oral routes. VP6 DNA vaccination by the nasal and oral routes induced the production of anti-VP6 IgA antibodies by intestinal lymphoid cells. Intramuscular DNA injection stimulated the production of serum anti-VP6 IgG but not serum anti-VP6 IgA antibodies. Protection against shedding of rotaviruses in stools after oral challenge with the murine EDIM rotavirus strain was investigated in the immunized mice. A significant reduction in the level of rotavirus a…

Immunoglobulin A[SDV]Life Sciences [q-bio]virusesAdministration OralAntibodies Viralmedicine.disease_causeImmunoglobulin GFecesMice0302 clinical medicineRotavirusVaccines DNAAntigens ViralMice Inbred BALB CVaccines Synthetic0303 health sciencesvirus diseasesVirus Shedding3. Good healthInfectious DiseasesMolecular MedicineFemaleDNA vaccineEnzyme-Linked Immunosorbent AssayBiologyInjections IntramuscularRotavirus InfectionsDNA vaccination03 medical and health sciencesAntigenmedicineAnimalsViral sheddingAdministration Intranasal030304 developmental biologyGeneral VeterinaryGeneral Immunology and Microbiologyintestinal IgA antibodyRotavirus VaccinesPublic Health Environmental and Occupational HealthVirologyImmunoglobulin ADisease Models AnimalrotavirusImmunizationImmunoglobulin GImmunologybiology.proteinCapsid ProteinsNasal administration030215 immunologyVaccine
researchProduct

Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection.

2015

The epithelium is the main entry point for many viruses, but the processes that protect barrier surfaces against viral infections are incompletely understood. Here we identified interleukin 22 (IL-22) produced by innate lymphoid cell group 3 (ILC3) as an amplifier of signaling via interferon-λ (IFN-λ), a synergism needed to curtail the replication of rotavirus, the leading cause of childhood gastroenteritis. Cooperation between the receptor for IL-22 and the receptor for IFN-λ, both of which were 'preferentially' expressed by intestinal epithelial cells (IECs), was required for optimal activation of the transcription factor STAT1 and expression of interferon-stimulated genes (ISGs). These d…

ImmunologyImmunoblottingMolecular Sequence DataGene ExpressionMice Transgenicmedicine.disease_causeRotavirus InfectionsCell LineMadin Darby Canine Kidney CellsInterleukin 22DogsInterferonRotavirusChlorocebus aethiopsmedicineImmunology and AllergyAnimalsHumansSTAT1Intestinal MucosaReceptors CytokineVero CellsMice KnockoutbiologyReverse Transcriptase Polymerase Chain ReactionInterleukinsInnate lymphoid cellInterleukinDrug SynergismEpithelial CellsVirology3. Good healthIntestinesMice Inbred C57BLSTAT1 Transcription FactorViral replicationImmunologybiology.proteinVero cellCytokinesCaco-2 CellsHT29 Cellsmedicine.drugNature immunology
researchProduct

Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review

2022

INTRODUCTION: Rotavirus is one of the most common pathogens causing diarrhea in children <5 years and has a major impact on childhood morbidity and mortality. Since the implementation of rotavirus vaccines into childhood immunization programs across Europe, there has been a reduction in rotavirus burden, including hospitalizations, outpatient cases, costs, and deaths. AREAS COVERED: A systematic literature review identified publications describing the clinical and economic impact of rotavirus vaccinations across Europe, from their introduction in 2006 to the end of 2020. A total of 3,137 articles were identified, of which 46 were included in the review. Included articles reported the impact…

ImmunologydiarrheaRotavirus InfectionsDrug DiscoveryHumansChildren; diarrhea; gastroenteritis; rotavirus; systematic literature review; vaccinesChildChildrenAgedPharmacologySettore MED/38 - Pediatria Generale e Specialisticarotaviruvaccines.Immunization ProgramsVaccinationRotavirus Vaccinessystematic literature reviewInfantvaccinesHospitalizationrotavirusMolecular MedicinegastroenteritiDelivery of Health Caregastroenteritis
researchProduct

Different transmission patterns of uncommon group A human rotavirus genotypes

2015

Infectious DiseasesTransmission (mechanics)lawVirologyHuman rotavirusGenotypeBiologyGroup AVirologylaw.inventionJournal of Clinical Virology
researchProduct

Dinotrema cavernicola sp. n. (Hymenoptera, Braconidae, Alysiinae), a new species of the genus Dinotrema Foerster from caves of Spain

2014

Dinotrema cavernicola sp. n. was collected in two caves in Spain. This is the first Dinotrema species known to occur in caves. This new species is described and compared to D. affine (Fischer, 1973) and D. collybiae Munk &amp; Peris-Felipo, 2014, species sharing a mid-longitudinal carina on the propodeum.

InsectaKulbastaviaDinotremaHymenopteraCarbotripluridaBraconidaetaxonomyGenusPropodeumlcsh:ZoologyBilaterialcsh:QL1-991AlysiinaePterygotageography.geographical_feature_categorybiologyCephalornisCircumscriptional namesCavernicolaBoltonocostidaeIchneumonoideaTiphiinaeCircumscriptional nameBraconidaeCoelenterataArthropodaHymenopteridaNephrozoaProtostomiaBasalZoologyDinotrema cavernicolaAnimaliaCircumscriptional names of the taxon undercavesCaveEumetabolaBraconidaeCephalornisEcology Evolution Behavior and SystematicsAlysiinaeCystomastacoides kiddoAlysiinaeAnimalianew speciesgeographyHymenopteraAnimaliaDipteraStrashila incredibilisbiology.organism_classificationHymenopteraNotchiaInsect ScienceAlysiiniEcdysozoaJournal of Hymenoptera Research
researchProduct